Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Kordon

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Neuroscience|October 31, 2022
Electrophysiological correlates of mindfulness in patients with major depressive disorderJan Sarlon, Annette B Brühl, Undine E Lang, et al.
Anxiety, Stress, and Coping|April 29, 2010
Relations between a ruminative thinking style and obsessive-compulsive symptoms in non-clinical samplesKarina Wahl, Andrea Ertle, Antje Bohne, et al.
Plos One|August 13, 2009
Brain potentials of conflict and error-likelihood following errorful and errorless learning in obsessive-compulsive disorderAnke Hammer, Andreas Kordon, Marcus Heldmann, et al.
Human Brain Mapping|July 22, 2014
Decreased limbic and increased fronto-parietal connectivity in unmedicated patients with obsessive-compulsive disorderMartin Göttlich, Ulrike M Krämer, Andreas Kordon, et al.
Biological Psychology|September 22, 2015
Resting-state connectivity of the amygdala predicts response to cognitive behavioral therapy in obsessive compulsive disorderMartin Göttlich, Ulrike M Krämer, Andreas Kordon, et al.
Postgraduate Medicine|September 10, 2011
Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPHAndreas Kordon, Kirsten Stollhoff, Käte Niederkirchner, et al.
Child and Adolescent Psychiatry and Mental Health|July 28, 2011
Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Michael Berek, Andreas Kordon, Ludger Hargarter, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2004
Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-upAndreas Kordon, Kai G Kahl, Andreas Broocks, et al.
Journal of Clinical and Experimental Neuropsychology|October 20, 2006
Neuropsychological impairment in obsessive-compulsive disorder--improvement over the course of cognitive behavioral treatmentAnne Katrin Kuelz, Dieter Riemann, Ulrike Halsband, et al.
Biological Psychiatry|October 4, 2005
Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorderKai G Kahl, Susanne Bens, Kristin Ziegler, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Neuroscience|October 31, 2022
Electrophysiological correlates of mindfulness in patients with major depressive disorderJan Sarlon, Annette B Brühl, Undine E Lang, et al.
Anxiety, Stress, and Coping|April 29, 2010
Relations between a ruminative thinking style and obsessive-compulsive symptoms in non-clinical samplesKarina Wahl, Andrea Ertle, Antje Bohne, et al.
Plos One|August 13, 2009
Brain potentials of conflict and error-likelihood following errorful and errorless learning in obsessive-compulsive disorderAnke Hammer, Andreas Kordon, Marcus Heldmann, et al.
Human Brain Mapping|July 22, 2014
Decreased limbic and increased fronto-parietal connectivity in unmedicated patients with obsessive-compulsive disorderMartin Göttlich, Ulrike M Krämer, Andreas Kordon, et al.
Biological Psychology|September 22, 2015
Resting-state connectivity of the amygdala predicts response to cognitive behavioral therapy in obsessive compulsive disorderMartin Göttlich, Ulrike M Krämer, Andreas Kordon, et al.
Postgraduate Medicine|September 10, 2011
Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPHAndreas Kordon, Kirsten Stollhoff, Käte Niederkirchner, et al.
Child and Adolescent Psychiatry and Mental Health|July 28, 2011
Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Michael Berek, Andreas Kordon, Ludger Hargarter, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2004
Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-upAndreas Kordon, Kai G Kahl, Andreas Broocks, et al.
Journal of Clinical and Experimental Neuropsychology|October 20, 2006
Neuropsychological impairment in obsessive-compulsive disorder--improvement over the course of cognitive behavioral treatmentAnne Katrin Kuelz, Dieter Riemann, Ulrike Halsband, et al.
Biological Psychiatry|October 4, 2005
Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorderKai G Kahl, Susanne Bens, Kristin Ziegler, et al.
Pageof 3